title: Implementing guidelines for the institutional use of factor VIIa (recombinant): a multidisciplinary solution.
authors.affiliation: South Carolina College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA. cnrudisill@gmail.com
authors.forename: Celeste N
authors.initials: CN
authors.lastname: Rudisill
authors.forename: Rebecca H
authors.initials: RH
authors.lastname: Hockman
authors.forename: Kathlene A
authors.initials: KA
authors.lastname: Degregory
authors.forename: Alan H
authors.initials: AH
authors.lastname: Mutnick
authors.forename: Barbara Gail
authors.initials: BG
authors.lastname: Macik
mesh_terms: D003362:Cost-Benefit Analysis; D017723:Drug Utilization Review; D015942:Factor VIIa / Q000191:economics / Q000627:therapeutic use*; D005572:Formularies, Hospital as Topic; D006470:Hemorrhage / Q000188:drug therapy; D010607:Pharmacy Service, Hospital / Q000592:standards*; D010606:Pharmacy and Therapeutics Committee; D017410:Practice Guidelines as Topic; D011994:Recombinant Proteins / Q000191:economics / Q000627:therapeutic use*
chemical_list: D011994:Recombinant Proteins; D015942:Factor VIIa